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ABSTRACT Sleeping sickness and Chagas disease are among the most severe diseases in Africa as well as Latin America.
These two diseases are caused by Trypanosoma spp. Recently, an enzyme of a glycolytic pathway, NAD-dependent
glycerol-3-phosphate dehydrogenase, of Leishmania mexicana was crystallized and its structure determined by x-ray
crystallography. This structure has offered an excellent template for modeling of the homologous enzymes from another
Trypanosoma species. Here, a homology model of the T. brucei enzyme based on the x-ray structure of LmGPDH has been
generated. This model was used as the starting point for molecular dynamics simulation in a water box. The analysis of the
molecular dynamics trajectory indicates that the functionally important motifs have both a very stable secondary structure and
tertiary arrangement.
INTRODUCTION
Trypanosomatids are the cause of two diseases, namely
sleeping sickness in Africa and Chagas disease in Latin
America. Official figures from the World Health Organiza-
tion state that between 10 and 20,000 new cases of sleeping
sickness occur annually, and that the total number of in-
fected people is in the order of 500,000 (Anker and Schaaf,
2000; Moore et al., 1999). In Africa two species of trypano-
somes are responsible for sleeping sickness, Trypanosoma
brucei gambiense in West and Central Africa, and Trypano-
soma brucei rhodesiense in Eastern Africa. The disease
caused by the former pathogen, if untreated, has a chronic
and protracted course lasting several years, whereas the
latter disease is acute and may lead to death in a few weeks.
Currently, there is no vaccine available against this disease
and the drugs in use are highly toxic and often not effective
because of drug resistance (Barrett, 1999). There is an
urgent need for new and better drugs. Recently several
different targets have been studied and suggested with the
reference to the metabolism of the parasite (Barrett et al.,
1999). Thus, the structures of a number of possible target
points, enzymes of metabolic pathways, have been eluci-
dated: triosephosphate isomerase for T. brucei (Wierenga et
al., 1991); glyceraldehyde-3-phosphate dehydrogenase for
T. brucei and Leishmania mexicana (Kim et al., 1995;
Vellieux et al., 1993); phosphoglycerate kinase for T. brucei
(Bernstein et al., 1997, 1998); glycerol-3-phosphate dehy-
drogenase (GPDH) for L. mexicana (Suresh et al., 2000);
and aldolase for T. brucei (Chudzik et al., 2000). One of the
most recently elucidated target points is an enzyme of the
glycolytic metabolic pathway of the parasite, GPDH. Tar-
geting the enzymes of this physiologically important meta-
bolic pathway should deprive the parasite of the energy
necessary for survival. T. brucei GPDH, the focus of the
present study, is a polypeptide consisting of 354 amino
acids forming a homodimer. It is expressed in the cytosol.
From the cytosol it is targeted to the glycosome, a special-
ized organelle encompassing nine glycolytic enzymes (Op-
perdoes and Borst, 1977). The targeting process occurs with
the aid of the peroxisomal targeting signal type 1 which is
an obligately C-terminal tripeptide of consensus sequence
SKL in LmGPDH and SKM in TbGPDH. TbGPDH shares
63.9% identity (346 residues overlap) with the correspond-
ing GPDH isolated from L. mexicana. The comparison of
the L. mexicana sequence with the other species such as T.
brucei brucei, Homo sapiens, and Mus musculus shows that
L. mexicana/T. brucei brucei shares 63.9% identity with
346 residues overlap; L. mexicana/M. musculus, 31.6%
identity with 285 residues overlap; L. mexicana/H. sapiens,
31.6% identity with 285 residues overlap; and H. sapi-
ens/M. musculus, 94% identity with 348 residues overlap.
The physiological function of the GPDH is the catalysis of
the interconversion of dihydroxyacetone to L-glycerol-3-
phosphate using NAD molecule as a cofactor. GPDH main-
tains the NAD/NADH balance in the glycosome by the
reoxidation of the NADH produced by glyceraldehyde-3-
phosphate dehydrogenase during glycolysis. The significant
structural difference between the human and the trypanoso-
mal system is in the binding site of adenosine portion of
NAD (Fig. 1). These differences should allow to develop
adenine analogs that selectively inhibit this trypanosomal
enzyme (Aronov et al., 1999), rendering it inactive. The
inhibition of GPDH will lead to the accumulation of dihy-
droxyacetone phosphate in the glycosome, which could be
very harmful to the parasite. The dihydroxyacetone phos-
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phate molecule spontaneously converts to methylglyoxy-
late, which is a toxic compound reacting with proteins
(Denise et al., 1999; Lo et al., 1994). Here homology
modeling and molecular dynamics (MD) studies of T. bru-
cei GPDH enzyme are presented. The structural features and
the structural stability of this homology model are exploited
for future possibility of rational in silico drug design.
METHODS
The protocol used to derive the T. brucei rhodesiense GPDH model is
divided into three phases: sequence analysis, model building, and model
evaluation. These three phases are reported and discussed in detail.
Homology modeling
The amino acid sequence (Q26756) of T. brucei rhodesiense was obtained
from Swiss-Prot protein sequence database (http://www.expasy.ch/sprot)
(Bairoch and Apweiler, 2000). A homology model was generated using
Swiss-Model, an automated protein modeling server (GlaxoSmithKline,
Research Triangle Park, NC) (Guex et al., 1999; Guex and Peitsch, 1997;
Schwede et al., 2000). T. brucei modeling procedure consisted of the two
steps: the first approach mode and the project mode modeling of a mono-
meric and homodimeric structure. The monomer homology model was
built on the two templates 1EVY, and 1EVZ from the Protein Data Bank
(PDB) (Berman et al., 2000) and the homodimer homology model was
built on a 1EVY template. The homology-modeling phase was followed by
the model evaluation phase. The structural stability of the models was
tested by means of MD simulations. Using a Gromacs force field (van der
FIGURE 1 Amino acid-sequence alignment and secondary structure assignment, using DSSP program, of L. mexicana, T. brucei, and H. sapiens GPDH.
The -helices are shown as blue rectangles, -sheets as red arrows, NAD-binding residues as black arrows, and active center residues as yellow arrows;
black bar on helix 4 indicates the kink in the helical structure. The assignment of the secondary structure was performed using DSSP program (Kabsch and
Sander, 1983).
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Spoel et al., 1996; van Gunsteren and Berendsen, 1987) that describes the
interatomic interactions, it was possible to solve the Newton motion
equations for the investigated system and to calculate how each atom’s
coordinates vary as a function of time.
MD simulations
The models obtained from the homology modeling were embedded in a
solvent box consisting of 8211 and 15,998 simple point charge water
molecules (Berendsen et al., 1981) for monomer and homodimer model,
respectively, giving the total number of atoms in the simulation of 27,940
and 54,608, respectively. A twin-range cutoff was used for long-range
interactions: 1.5 nm for electrostatic interactions and 1.2 nm for van der
Waals interactions. The Shake algorithm was used to constrain hydrogen
bond lengths (Ryckaert et al., 1977). The simulation was performed under
the normal pressure and temperature conditions. Thus, a constant pressure
of 1 bar applied independently in all three directions was used with a
coupling constant of p  0.5 ps and compressibility of 4.5 e
5 bar1.
Water and protein molecules were coupled separately to the thermal bath
at 300 K, using a coupling constant T  0.1 ps (Berendsen et al., 1984).
MD simulations were performed on a 2  733 MHz Pentium III, Dell 420
Workstation (Intel, Santa Clara, CA), taking79 and120 h of CPU time
per nanosecond of simulation for monomeric and homodimeric structures.
All simulations were performed using Gromacs v. 3.0 software (Berendsen
et al., 1995; Lindahl et al., 2001; van der Spoel et al., 2001). Both
simulations consisted of two phases: a short 20-ps canonical ensamble
simulation allowing for randomization of water molecules surrounding the
protein molecule and a 500-ps isobaric-isothermal ensamble simulation.
The protein as well as water parameters were those of the Gromacs force
field (van der Spoel et al., 1996; van Gunsteren and Berendsen, 1987).
Structural diagrams were prepared using the programs VMD (Hum-
phrey et al., 1996), Swiss-Model (Guex and Peitsch, 1997), and Pov-Ray
(http://www.povray.org). Secondary structure analysis was performed us-
ing the program DSSP (Kabsch and Sander, 1983). Other analyses were
performed using scripts included with the Gromacs distribution.
RESULTS AND DISCUSSION
Sequence alignment analysis
The sequence alignment was performed using SIM–a
conventional alignment tool for protein sequences
(Huang and Miller, 1991). The L. mexicana (P90551) and
T. brucei rhodesiense (Q26756) GPDH amino acid-se-
quence alignment shows a high percentage of identity
between these two sequences (63.9% identity was calcu-
lated using a Block Substitution Matrix (BLOSUM62)
(Henikoff and Henikoff, 1992)). The stretches of highly
conserved residues within the sequence of L. mexicana-T.
brucei rhodesiense have been located and are presented
in Fig. 1. The residues involved in NAD binding as well
as substrate binding are fully conserved (NAD-binding
residues, black arrows; active center, yellow arrows (Fig.
1)). The analysis of the placing NAD-binding and active
site residues versus secondary structure pattern indicates
that they reside within the regions of well defined sec-
ondary structures. In contrast, quite low sequence iden-
tity among L. mexicana, T. brucei rhodesiense, and H.
sapiens is observed (31.6% identity with 285 residues
overlap). The analysis of the conservation of the residues
involved in NAD-binding shows that Ser23 and Lys125
are fully conserved in L. mexicana, T. brucei, and H.
sapiens species. However, Met46 is replaced by phenyl-
alanine residue and E300 by glutamine in H. sapiens. As
one could expect, the residues involved in substrate spec-
ificity (K125, K210, D263, and T 267) are fully con-
served among the three species.
The analysis of the homologous models and
general structural features
The quality of both homology models (monomer and ho-
modimer) (Fig. 2, A and B), returned from SWISS-MODEL
was evaluated by analysis of WhatCheck program report
(Hooft et al., 1996; Rodriguez et al., 1998). The accuracy of
a model was evaluated by analysis of root mean square
(rms) deviation of a model from its template. Thus, the rms
of the backbone atoms between the monomeric model and
the two templates 1EVA and 1EVZ is equal (0.29 Å and
0.23 Å) and the rms for the homodimeric model and 1EVA
template structure is equal (0.17 Å). The inspection of
B-factors shows very low confidence for the loop consisting
of residue 285–288 in T. brucei sequence. It is the sequence
that corresponds to the missing residues 294–296 of the
crystal structure of L. mexicana. The rms z-score for bond
angles and bond lengths of a monomer are equal to 1.140
and 0.669, respectively (z-score is a transformation of raw
scores into a standard form and rms z-score is used as a
measure of a drift from the expected behavior in a given set
of values). There are also 37 residues with abnormal bond
angles. Abnormal packing environment for at least three
sequential residues with a questionable packing environ-
ment was found. This indicates that these residues are part
of a strange loop. Nine residues with forbidden phi/psi
combinations are also present in the monomeric homology
model. The quality of the homodimer homology model is as
follows. The rms z-score for bond angles is equal (1.037),
which is close to the data obtainable for high resolution of
x-ray structures. There are four residues with abnormal
torsion angles; these are Ile168(A), Pro312(A), Ile168(B),
Pro313(B), and Gly15(B) (A and B stands for the subunits
of the homodimeric structure). The rms z-score for bond
length is 0.622. There are also 20 residues with disallowed
phi/psi combinations. There is a large number of pairs with
abnormally short interactomic distances. A large B-factor of
50 is observed for buried atoms (the average value for a
room temperature x-ray study lies between 10 and 20). The
analysis of these results indicates good quality of the ho-
mologous models. However, the further refining of the
model is desirable. The tertiary structure of TbGPDH con-
sists of the two well defined domains, the N-terminal and
the C-terminal domain. The DSSP (Kabsch and Sander,
1983) secondary structure analysis shows that the N-termi-
nal NAD-binding domain consists of residues 1 to 189,
which are arranged into eight -sheets and seven -helices.
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The -sheet 7 consists of residues 159–165 and is antipa-
rallel to the -sheet 6 (residues 141–145). The -sheet
number 8 is parallel to the -sheet seven. All -sheets are
flanked by the two -helical structures, creating long flank-
ing helices (helix 4 has a “kink” at Ser99 residue) and a
number of shorter helices at the bottom of the structure. The
-sheets 7 and 8 are solvent exposed. The first - unit
contains the highly conserved GxGxxG NAD-binding motif
(residues 15–20). The N-terminal and the C-terminal do-
mains are connected by the short loop comprising three
residues 191 to 193. The C-terminal substrate-binding do-
main consists of residues 193 to 354. The residues 194 to
336 are organized into eight -helical structures. Helices 1
and 2 are particularly long and consist of 23 and 21 residues,
respectively. They are antiparallel with an angle of 151.95°.
The shortest distance between the straight lines connecting
the endpoints of helices is equal to 0.585 nm. Residues 336
to 349 adopt a random coil structure. The subunit interac-
tions are of hydrophobic origin with small contribution of
hydrogen bonding (Fig. 3, A and B; Fig. 10). The visual
inspection of the interaction surfaces between the N- and the
C-terminal domain show that the hydrophobic surface of the
FIGURE 2 The tertiary structure of the TbGPDH monomer (A) and homodimer (B). The -helices are shown as violet cylinders, -sheets as yellow
arrows, the turns are colored blue, and the random coil structures in white. Color and the secondary structure assignment are based on the output from the
DSSP program (Kabsch and Sander, 1983).
FIGURE 3 (A) The surface of the N-terminal domain is colored according to the hydrophobicity scale (Kyte and Doolittle, 1982); the arrow shows a
contact area between the N- and C-terminal domains. (B) The surface of the C-terminal domain is colored according to the hydrophobicity scale (Kyte and
Doolittle, 1982); the arrow shows a contact area between the N- and C-terminal domains. Color code: blue (hydrophobic)  red (hydrophilic).
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N-terminal domain is much larger than the corresponding
surface of the C-terminal domain (Fig. 3, A and B). The
analysis of the number of hydrogen bonds and the quality of
the interacting surfaces between the domains of the
monodimer indicates that domains are bound together by
means of hydrophobic interactions within the monomeric
structure. The interactions between subunits of the ho-
modimeric structure are also of hydrophobic origin. There
is, however, a specific motif “zipping” together the sub-
units. It consists of the helices 2 and 3 of the C-terminal
domain (Fig. 4). This zipping structure is shielded from the
solvent environment by the two -sheets at each side, sheets
7 and 8 of the N-terminal domain. The analysis of the
accessibility of NAD-binding site and the putative substrate
binding site shows that the accessibility is not affected by
the aggregation process and creation of a homodimeric
structure.
NAD-binding site
The LmGPDH crystal structure in complex with NADH
(Suresh et al., 2000) allowed for identification of the resi-
dues directly involved in NAD-binding. Within the TbG-
PDH sequence these residues, Glu293, Lys118, Ser16, and
Met39, are fully conserved. The NAD-binding domain con-
sists of four residues. Three residues belong to the N-
terminal domain and the one residue, the Glu293, is the first
residue of the sixth helix of the C-terminal domain (13,
Fig. 1). The striking feature is that most of the residues
involved in NAD-binding are located within the well de-
fined secondary structures. Only Lys118 is located in the
middle of the disordered loop connecting helices 5 and 6
of the N-terminal domain. The net of distances and their
standard deviations during the simulation that characterize
the NAD-binding site of the TbGPDH are summarized in
Table 1.
Structural fluctuations
Time-dependent C rms deviation (RMSD) has been used
to provide a picture of the global drift of the homology
model during the simulation period. Thus, during the sim-
ulation, the RMSD drift of C atoms (for both the monomer
and homodimer structures) from the initial protein structure
was determined (Fig. 5). The drift observed for the mono-
meric structure reaches a plateau after 0.35 ns of simula-
tion and is equal to0.4 nm. A similar behavior can also be
observed for the homodimeric structure. The initial rise of
FIGURE 4 The “zipping” motif of the homodimeric structure. 1A, B
helix 2 of the subunit A and B; 2A, B helix 3 of subunit A and B of the
C-terminal domain; 3A, B -sheets 7 of subunit A and B; and 4A, B -sheet
8 of subunit A and B of the N-terminal domain.













E293OE1-K118N 0.842 0.660  0.093 0.817  0.108 0.842  0.078
E293OE1-S16OG 1.433 1.104  0.119 1.316  0.215 1.353  0.106
K118N-S16OG 1.425 1.3106  0.082 1.322  0.175 1.270  0.101
S16OG-M39N 0.494 0.5028  0.034 0.526  0.058 0.797  0.112
E293E1-M39N 1.759 1.42648  0.146 1.629  0.079 1.96  0.131
K118N-M39N 1.731 1.49967  0.160 1.626  0.069 1.580  0.144
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the C RMSD over the first 300 ps is possibly attributable
to the relaxation motion of the protein or inaccuracies in the
force field. To examine the fluctuation of the structure on a
residue-by-residue basis, the time-averaged (last 200 ps of
simulation) rms fluctuation (RMSF) of C atoms (Fig. 6)
has been analyzed. The averaging time period, 300 ps to 500
ps, was determined based on the observation of the C
RMSD drift. The analysis of Fig. 6, A and B shows that
RMSFs for a monomeric structure adopt the largest values
at the C terminus where RMSF is equal 0.5 nm. Such
large fluctuation value observed for the C terminus is at-
tributable to the presence of unstructured free end consisting
of residues 335 to 350. The central region consisting of a set
of -sheets and -helices undergoes rather small fluctua-
tions with the maximum in the order of 0.15 nm. This
stable behavior of the central region is attributable to the
network of hydrogen bonds stabilizing these secondary
structures. The RMSF distribution observed for ho-
modimeric structure has a much lower (0.18 nm) and
more uniformly distributed fluctuation than those observed
for the monomeric structure. The more stable behavior of
the homodimeric structure can be explained by the nature of
the interactions between the units of the homodimer and by
the wrapping of the C-terminal ends of each monomer
around one another. Additional information on the struc-
tural flexibility is offered by the analysis of time-dependent
secondary structure fluctuations (Fig. 7). Analysis of Fig. 7
reveals very high stability of the motifs with the well
defined secondary structure. Thus, -sheets and -helices
observed within the TbGPDH structure are very stable dur-
ing the whole simulation period, whereas turns become
bends, and vice versa. The lowest time-dependent stability
and lowest structure conservation is observed for the C-
terminal end. This observation is in agreement with the
results of RMSF analysis. The comparison of the stability
patterns for the secondary structures within the monomeric
and the homodimeric structure indicates slightly greater
stability for a dimeric structure. This observation is in
agreement with a biologically active structure of a GPDH
enzyme.
Distance fluctuations of NAD-binding residues
The analysis of the time-dependent fluctuation of the dis-
tances between the atoms directly involved in creation of
NAD-binding site, for both monomer and homodimer,
shows that the distances are fairly stable during the simu-
lation time (Table 1). The analysis of Table 1 and the
comparison with the results of the x-ray studies on LmG-
PDH shows that distance differences are within the range of
0.1 nm. Furthermore, one can observe that the distances
derived for the homodimeric structures are slightly shorter
than those observed for monomeric structures. This tighter
packing could be explained by increased stability of the
homodimeric structure versus the monomeric structure. The
results obtained also show that the shape of the NAD-
binding site stays practically constant during the simulation
time.
GxGxxG NAD-binding motif.
All NAD-dependent GPDHs studied to date have the highly
conserved motif, GxGxxG (Wierenga et al., 1986). This
motif is also present within the sequence of TbGPDH and
comprises the following amino acids GSGAFG (residue
15–20, Fig. 1). It has also been shown that the core topol-
ogies of the classical nicotinamide-binding proteins overlap
very well. The RMSD of backbone atoms superposition
ranges from 0.07 to 0.47 nm (Bellamacina, 1996). To esti-
mate the time-dependent stability of the GxGxxG motif, the
RMSD fluctuation of the six residues building the NAD-
binding motif was analyzed. The result is presented in Fig.
8, A and B. The mean fluctuation versus simulation time is
FIGURE 5 Drift of protein structure from the initial model. The RMSD
of all C atoms from the starting structure is shown as a function of time.
(–‚—monomer, –E– homodimer)
FIGURE 6 Fluctuation of protein coordinates. The RMSFs of the C
coordinates from their time-averaged values (last 200-ps simulation) are
shown as a function of residue number for the monomeric (A) and ho-
modimeric (B) structures.
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in the order of 0.066 nm, with the standard deviation of 
0.015 nm and 0.06  0.014, 0.115  0.015 for monomeric
and homodimeric chains A and B, respectively. These low
values of fluctuations indicate that the structure of this
functionally important unit is very stable. However, a slight
increase in flexibility is observed for the GxGxxG motif
residing within the chain B of the homodimeric structure.
The overall structural stability could be attributable to the
very stable secondary structures created by residues 9–14, a
-structure and 21–28, an -helix.
The x-ray analysis of the LmGPDH in complex with
NADH allowed delineation of a putative active site of this
enzyme. The residues Lys125, Lys210, Asp263, and Thr267
were designated to be involved in substrate binding or
catalysis. The analysis of the sequence alignment (Fig. 1)
shows that these residues are fully conserved within the T.
brucei sequence. Thus, the analysis of the active site of
LmGPDH can be extended on the active site of TbGPDH.
Additionally, the structure-structure similarity search using
VAST (The National Center for Biotechnology Informa-
tion) service allowed for the mapping of the sequence
conservation onto the secondary structure of the protein
(Fig. 9). The analysis of the color map indicates that by
approaching the core of the protein, the higher structural and
sequential conservation is observed. Additionally a struc-
tural similarity was discovered between the crystal structure
of the N-(1-D-carboxylethyl)-L-norvaline dehydrogenase
from Arthrobacter species (PDB code: 1BG6).
Interdomain interactions and structure stability
The TbGPDH molecule consists of two well defined do-
mains. The N-terminal domain consists of residues 1–189
and the C-terminal domain of 192–349. These two domains
FIGURE 7 Secondary structure fluctuations (analyzed using the DSSP program (Kabsch and Sander, 1983)) as a function of time for the simulation of
the GPDH enzyme.
FIGURE 8 GxGxxG pattern C-atom RMSD fluctuation as a function
of time. (A) Monomeric structure; (B) Homodimeric structure (–E– chain
A, –‚– chain B).
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are linked by a short three-residue loop. The analysis of the
fluctuation of the centers of mass of these two domains as a
function of time (Fig. 10, A–D) and the calculation of the
changes of the number of hydrogen bonds (Fig. 11, A–D)
between these two domains reveals the forces stabilizing the
molecule and the overall shape of the molecule. The anal-
ysis of the distances between the centers of mass between
these two domains shows that these distances are in the
range of 0.255–0.344 nm with the range of fluctuations
between 0.013 and 0.020 nm. It is noticeable that distances
between the centers of mass of domains as well as subunits
decrease during the simulation time. However, these fluc-
tuations are effectively negligible when the size of the
protein is taken into account. The analysis of the hydrogen
bonding profile shows that after 300 ps of the simulation,
the number of hydrogen bonds between domains differs for
the monomeric and homodimeric structures. Thus, one can
observe that the average number of hydrogen bonds after
300 ps of simulation for monomeric structure is seven and
eight for the chain A and B of homodimer. There is, how-
ever, a significant increase in the number of hydrogen-
bonds (four to eight hydrogen bonds increase after 300 ps of
simulation) within the unit B of the homodimeric structure.
The number of hydrogen bondings between subunits of the
homodimeric structure is slightly larger and is equal to 15.
The total number of hydrogen bonds observed indicates that
hydrophobic forces are responsible for interactions between
domains and between subunits. The comparison of Figs. 10
and 11 does not reveal any specific correlation between the
distances of centers of mass and the number of hydrogen
bonds. To validate the overall shape stability, the RMSD
fluctuations of all atoms within the subdomains of both the
monomeric structure and the subunits of the homodimeric
structure were analyzed (Fig. 12). The analysis of Fig. 12
shows that the RMSD of all atoms for the N-terminal
domain of the monomeric structures oscillates0.2 nm and
for the C-terminal 0.4 nm. Similar analyses performed on
the homodimeric structures show that the RMSD of subunit
A oscillates 0.27 nm and for subunit B 0.32 nm. Con-
FIGURE 9 Sequence conservation between LmGPDH and TbGPDH
mapped onto the secondary structure of the protein. The color code is
scaled from red to blue depending on the number of different residues in
the column. The variety is weighted by a Block Substitution Matrix
(BLOSUM62).
FIGURE 10 The distances of the centers of mass of the N- and the
C-terminal domain versus simulation time for the monomeric structure (A)
and the homodimeric structure (B, C) and between the subunits of the
homodimeric structure (D).
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sidering the size of the protein, it is possible to state that the
overall shape of the molecule is remarkably stable and after
300 ps of simulation does not undergo any significant
changes.
CONCLUSION
The TbGPDH homology model built on the template of the
LmGPDH enzyme may be used as a valid target molecule
for designing antitrypanosomal drugs. The MD simulation
data analysis reveals that the TbGPDH enzyme consists of
the two very stable domains connected by a short three-
residue loop. The interdomain interactions are based on
hydrophobic interactions with some assistance from hydro-
gen bonding. The analysis also shows that the main struc-
tural features of the NAD-binding domain are very stable.
The comparison of the dynamic trajectories of the mono-
meric and homodimeric structures shows insignificant dif-
ferences, indicating that the solvent-exposed large hydro-
phobic area responsible for monomer-monomer interactions
does not undergo any structural changes during the MD
simulation of a monomeric structure. This behavior is most
probably owed to hydrogen bonding stabilizing the second-
ary structure motifs (helices, -sheets) within these regions.
The energy of these bonds is high enough to compensate for
the unfavorable solvent-hydrophobic surface interactions.
Considering the stability differences between monomer and
homodimer, the monomeric structure may be used as a
template for drug-designing studies. Thus, selective inhibi-
tors that have a similar shape/size to the NAD molecule can
be designed. A similar approach has been used in the
designing of the glyceraldehydes-3-phosphate dehydroge-
nase inhibitors (Aronov et al., 1999, 1998; Bressi et al.,
2000; Kennedy et al., 2001). The inhibitor designing should
be based on the exploitation of the structural differences
between the human and the trypanosomal -- motif
encompassing the GxGxxG sequence. A very good RMS
fitting between the LmGPDH and TbGPDH homology
model provides the unique chance to exploit the information
concerning the NAD binding as a template for the future
docking experiment using NAD analogs.
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